Stockreport

Korro to Participate in Upcoming Investor Conferences

Korro Bio, Inc.  (KRRO) 
PDF CAMBRIDGE, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on developing a new class [Read more]